Skip to content

Benefit of the Use of 3D Models and Tools in Hepatectomy Planning for Hepatocarcinomas

Multicentric Study Determining the Benefit of the Use of 3D Models and Tools in Hepatectomy Planning for Hepatocarcinomas

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03382327
Acronym
3D-HAPPI
Enrollment
136
Registered
2017-12-22
Start date
2017-10-16
Completion date
2020-10-16
Last updated
2021-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocarcinoma

Keywords

Surgical planning, CT-scan, MRI, 3D model, Hepatocarcinoma eligible for surgical resection

Brief summary

The aim of this study is to assess the benefit of 3D models in the planning of hepatic resection by comparing the changes in the surgical plan based on the analysis of conventional preoperative images (CT-scan and MRI), compared to the surgical plan based on the analysis of 3D reconstruction.

Detailed description

The detailed anatomical description of the liver described by Couinaud in 1954 is the basis for hepatic surgery. Surgical resection is the approach leading to the best survival rate in case of liver cancer. In hepatocarcinomas, systematic removal of the infected liver segment is considered the most effective technique to eliminate tumour, potential satellite nodules and avoid vascular spread. Resectability rate highly depends on the analysis of preoperative images. However, in 20% of cases, there are modifications compared with the initial surgical plan leading to an increase in morbidity rate. In 2002, Couinaud highlighted the difficulty of identifying portal pedicles, especially because of anatomical variations, and recommended the use of a three-dimensional reconstruction from images provided by a helical scanner. The hypothesis of the study is that 3D models would improve surgical planning leading to a decrease in intra-operative adjustments and mortality. The aim of this multicentric, prospective study is to assess the benefit of 3D models in the surgical management of hepatocarcinomas, more specifically in the detailed analysis of 3D vascular structures and in the surgery planning with resection merges evaluation. The validation of this virtual method will be built on the comparison of the surgical plan based on the analysis of conventional preoperative images (CT-scan and MRI) and the surgical plan based on the analysis of 3D reconstruction.

Interventions

PROCEDURESurgical planning

Two surgical plans will be established preoperatively. The first plan will be based on standard preoperative images (CT-scan, MRI) review. The second plan will be based on the 3D model review. Both will be compared to the actual surgery performed in the operating room.

Sponsors

IHU Strasbourg
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient with a hepatocarcinoma, eligible for surgical resection * Patient over 18 years old * Patient able to understand the study and provide written informed consent * Patient affiliated to the French social security system.

Exclusion criteria

* Patient with other liver tumours * Patient whose general condition is not suitable for study participation (WHO ≥ 3) * Patient with a condition preventing its participation to study procedures, according to investigator's judgment * Patient with contraindications to injected CT-scan or MRI: allergic reaction to contrast agents, kidney failure, pacemaker, claustrophobia * Pregnancy or breastfeeding * Patient in exclusion period (determined by a previous study or in progress) * Patient in custody * Patient under guardianship.

Design outcomes

Primary

MeasureTime frameDescription
Comparison of the intra-operative modifications ratesAt time of surgeryModifications in the surgical planning compared to the plan based on the analysis of standard preoperative images (CT-scan and MRI) and the plan based on the 3D model analysis: changes in surgical resection type (by specifying the surgical act: tumorectomy, segmentectomy, bi-segmentectomy or lobectomy…) or no surgery.

Secondary

MeasureTime frameDescription
Comparison of vascular network anatomyAt time of surgeryComparison of vascular network anatomy based on 3D model and standard preoperative images analysis.
Choice of surgical planAt time of surgerySurgery done according to a) surgical plan based on standard preoperative images analysis, b) surgical plan based on 3D model analysis or c) alternative approach (by specifying the surgical act: tumorectomy, segmentectomy, bi-segmentectomy or lobectomy….)
Modification of the initial surgical plan, if applicableAt time of surgeryDescription of perioperative events having modified the initial surgical plan.
Comparison of resection mergesAt time of surgeryComparison of expected resection merges based on standard preoperative images and 3D model analysis and actual resection merge in the operating room.
Comparison of tumor(s) locationAt time of surgeryComparison of tumor(s) location based on 3D model and standard preoperative images analysis.
Comparison of surgical merge sizeAt time of surgeryComparison of surgical merge size (mm) based on 3D model and standard preoperative images analysis.
MorbidityAt time of surgery and 3 months after surgeryMorbidity specific to the procedure.
MortalityAt time of surgery and 3 months after surgeryMortality specific to the procedure.
Preoperative images independent analysis3 yearsAnalysis of preoperative images (CT-scan/MRI and 3D model) by a senior team on one hand, and a junior team (surgeons + radiologists) on the other hand.
Comparison of resection volumesAt time of surgeryComparison of expected resection volumes based on standard preoperative images and 3D model analysis and actual resection volume in the operating room.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026